Diastolic dysfunction medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(8 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The treatment of diastolic dysfunction involves aggressive management of the underlying disorder that is causing the diastolic dysfunction such as diabetes or high blood pressure. mild diastolic dysfunction that is well tolerated requires no specific treatment.  It takes a longer period of time for a stiff left ventricle to fill, and therefore rate control is a critical part of the acute therapy diastolic dysfunction.
The chronic treatment of diastolic dysfunction involves aggressive management of the underlying disorder that is causing the diastolic dysfunction such as [[diabetes]] or [[hypertension]]. Mild diastolic dysfunction that is well tolerated requires no specific treatment.  Rate control is an important part of the acute therapy of the patient with diastolic heart failure.  It takes a longer period of time for a stiff left ventricle to fill, and therefore rate control is a critical part of the acute therapy of diastolic dysfunction.


==Acute Treatment of Diastolic Heart Failure==
==Acute Treatment of Diastolic Heart Failure==
Line 11: Line 11:


=== Diuresis===
=== Diuresis===
Diuresis may reduce acute volume overload.
=== Relief of Ischemia===
=== Relief of Ischemia===
Acute [[myocardial ischemia]] leads to diastolic dysfunction which increases left atrial pressure and causes [[pulmonary edema]].
Acute [[myocardial ischemia]] leads to diastolic dysfunction which increases left atrial pressure and causes [[pulmonary edema]].
 
== Chronic Treatment of Diastolic Heart Failure==
== Chronic Treatment of Diastolic Heart Failure==
=== Afterload Reduction===
=== Afterload Reduction===
There is some evidence that [[calcium channel blocker]] drugs may be of benefit in reducing ventricular stiffness in some cases.  Likewise, treatment with [[angiotensin converting enzyme inhibitors]] such as [[enalapril]], [[ramipril]], and other ACE inhibitors may be of benefit due to their effect on [[ventricular remodeling]].
==ACA/AHA 2009 Guidelines for the Diagnosis and Management of Heart Failure in Adults<ref name="pmid19324966">{{cite journal| author=Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al.| title=2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. | journal=Circulation | year= 2009 | volume= 119 | issue= 14 | pages= e391-479 | pmid=19324966 | doi=10.1161/CIRCULATIONAHA.109.192065 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19324966  }} </ref> (DO NOT EDIT)==


==Medical Therapy==
===Patients With Heart Failure and Normal Left Ventricular Ejection Fraction===
==ACA/AHA 2009 Guidelines for the Diagnosis and Management of Heart Failure in Adults: Patients With Heart Failure and Normal Left Ventricular Ejection Fraction<ref name="pmid19324966">{{cite journal| author=Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al.| title=2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. | journal=Circulation | year= 2009 | volume= 119 | issue= 14 | pages= e391-479 | pmid=19324966 | doi=10.1161/CIRCULATIONAHA.109.192065 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19324966  }} </ref> (DO NOT EDIT)==


{|class="wikitable"
{|class="wikitable"
Line 54: Line 59:
<nowiki>"</nowiki>'''3.''' The usefulness of [[digitalis]] to minimize symptoms of heart failure in patients with heart failure and normal left ventricular ejection fraction is not well established. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
<nowiki>"</nowiki>'''3.''' The usefulness of [[digitalis]] to minimize symptoms of heart failure in patients with heart failure and normal left ventricular ejection fraction is not well established. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
|}
|}
In diastolic dysfunction, the heart has poor response to stress-
* [[Tachycardia]], increased heart rate would hamper proper and complete filling of left ventricle.
* [[Hypertension]], especially if it is acute in onset or refractory to treatment increases the stress on the walls of the ventricle, which in turn leads to [[hypertrophy]] and impaired filling.
*
By and large, diastolic dysfunction is chronic process (except during acute [[ischemia]]).
The role of specific treatments for diastolic dysfunction ''per se'' is unclear. There is some evidence that [[calcium channel blocker]] drugs may be of benefit in reducing ventricular stiffness in some cases. Likewise, treatment with [[angiotensin converting enzyme inhibitors]] such as [[enalapril]], [[ramipril]], and many others, may be of benefit due to their effect on [[ventricular remodeling]].
A major treatment consideration in people with diastolic dysfunction is when [[pulmonary edema]] develops. Unlike treatment of pulmonary edema occurring the setting of [[systolic]] dysfunction (where the primary problem is poor ventricular pumping as opposed to poor filling), the treatment of [[pulmonary edema]] complicating diastolic dysfunction emphasizes [[heart rate]] control (i.e. lowering it). [[Diuretics]] are often given as well. The role of [[afterload]] reduction in this setting is unknown.


==References==
==References==
Line 76: Line 69:
[[Category:Cardiomyopathy]]
[[Category:Cardiomyopathy]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs content]]
[[Categor:Best pages]]
[[Category:Up-To-Date cardiology]]
[[Category:Up-To-Date]]

Latest revision as of 12:10, 30 January 2013

Diastolic dysfunction Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Diastolic dysfunction from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Echocardiography

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diastolic dysfunction medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diastolic dysfunction medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diastolic dysfunction medical therapy

CDC on Diastolic dysfunction medical therapy

Diastolic dysfunction medical therapy in the news

Blogs on Diastolic dysfunction medical therapy

Directions to Hospitals Treating Diastolic dysfunction

Risk calculators and risk factors for Diastolic dysfunction medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shankar Kumar, M.B.B.S. [2]

Overview

The chronic treatment of diastolic dysfunction involves aggressive management of the underlying disorder that is causing the diastolic dysfunction such as diabetes or hypertension. Mild diastolic dysfunction that is well tolerated requires no specific treatment. Rate control is an important part of the acute therapy of the patient with diastolic heart failure. It takes a longer period of time for a stiff left ventricle to fill, and therefore rate control is a critical part of the acute therapy of diastolic dysfunction.

Acute Treatment of Diastolic Heart Failure

Rate Control

It takes a longer period of time for a stiff left ventricle to fill, and therefore rate control is a critical part of the acute therapy diastolic dysfunction. Furthermore, in atrial fibrillation there is a failure of atrial kick to augment the filling of the left ventricle.

Diuresis

Diuresis may reduce acute volume overload.

Relief of Ischemia

Acute myocardial ischemia leads to diastolic dysfunction which increases left atrial pressure and causes pulmonary edema.

Chronic Treatment of Diastolic Heart Failure

Afterload Reduction

There is some evidence that calcium channel blocker drugs may be of benefit in reducing ventricular stiffness in some cases. Likewise, treatment with angiotensin converting enzyme inhibitors such as enalapril, ramipril, and other ACE inhibitors may be of benefit due to their effect on ventricular remodeling.

ACA/AHA 2009 Guidelines for the Diagnosis and Management of Heart Failure in Adults[1] (DO NOT EDIT)

Patients With Heart Failure and Normal Left Ventricular Ejection Fraction

Class I

"1. Physicians should control systolic and diastolic hypertension in patients with heart failure and normal left ventricular ejection fraction, in accordance with published guidelines. (Level of Evidence: C)"

"2. Physicians should control ventricular rate in patients with heart failure and normal left ventricular ejection fraction and atrial fibrillation. (Level of Evidence: C)"

"3. Physicians should use diuretics to control pulmonary congestion and peripheral edema in patients with heart failure and normal left ventricular ejection fraction. (Level of Evidence: C)"

Class IIa

"1. Coronary revascularization is reasonable in patients with heart failure and normal left ventricular ejection fraction and coronary artery disease in whom symptomatic or demonstrable myocardial ischemia is judged to be having an adverse effect on cardiac function. (Level of Evidence: C)"

Class IIb

"1. Restoration and maintenance of sinus rhythm in patients with atrial fibrillation and heart failure and normal left ventricular ejection fraction might be useful to improve symptoms. (Level of Evidence: C)"

"2. The use of beta-adrenergic blocking agents, ACEIs, ARBs, or calcium antagonists in patients with heart failure and normal left ventricular ejection fraction and controlled hypertension might be effective to minimize symptoms of heart failure. (Level of Evidence: C)"

"3. The usefulness of digitalis to minimize symptoms of heart failure in patients with heart failure and normal left ventricular ejection fraction is not well established. (Level of Evidence: C)"

References

  1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG; et al. (2009). "2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation". Circulation. 119 (14): e391–479. doi:10.1161/CIRCULATIONAHA.109.192065. PMID 19324966.

Template:WH Template:WS Categor:Best pages